Joel Gelfand, MD, MSCE, FAAD; Peter Dehnel, MD; and Steven Feldman, MD, PhD, provide an overview of psoriasis, including diagnosis, genetic influence, and progression ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) ...
An international panel of more than 30 experts has developed a consensus definition and diagnostic criteria for generalized pustular psoriasis (GPP). The new definition, published in JAMA Dermatology, ...
Psoriasis -- the chronic condition that causes red, scaly, itchy patches on your skin-- comes and goes. Your psoriasis can change in how serious it is and how often you have symptoms. Psoriasis ...
A high proportion of patients with moderate to severe plaque psoriasis achieved long-term on-treatment remission for 3 years ...
Depending on the definition used, there are large variations in the proportion of patients identified as having moderate-to-severe psoriasis. HealthDay News — Depending on the definition used, there ...
More than half of people with psoriasis say they’ve used complementary and alternative medicine to help manage their disease. Vitamins and supplements are often a staple complementary therapy. Of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results